Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02926482 · ClinicalTrials.gov registry record · NA
Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT02926482 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 76 participants.
The verdict
NCT02926482, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
This is a cluster-randomized controlled trial designed to increase the availability of buprenorphine and extended-release naltrexone treatment capacity for opioid use disorder (OUD). The intervention being tested is a bundle of OUD pharmacotherapy capacity building practices called the Prescriber Recruitment Bundle (PRB). For the study, 70 organizations will be identified and recruited, and those organizations will then be randomized into one of two arms: 1) control, and 2) intervention: organizations implementing the PRB using the Network for Improvement of Addiction Treatment (NIATx) Organizational Change Model. The primary research question is to test the impact of the PRB, relative to the control, on increasing buprenorphine treatment slots and extended-release naltrexone capacity and the number of patients receiving these pharmacotherapies.
Interventions
- BEHAVIORAL Prescriber Recruitment Bundle (PRB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-10-26 |
| Est. Completion | 2019-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02926482
The ClinicalTrials.gov registry entry for NCT02926482 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Prescriber Recruitment Bundle (PRB) is the first listed.
NCT02926482 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02926482 about?
NCT02926482 is a clinical study titled "Intervention to Expand Opioid Use Disorder Treatment Pharmacotherapy Prescribers". This is a cluster-randomized controlled trial designed to increase the availability of buprenorphine and extended-release naltrexone treatment capacity for opioid use disorder (OUD). The intervention being tested is a bundle of OUD pharmacotherapy capacity building practices called the Prescriber Re...
What is the current status of trial NCT02926482?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2016-10-26. Estimated completion is 2019-10.
What interventions are being tested in trial NCT02926482?
The interventions under investigation include: Prescriber Recruitment Bundle (PRB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02926482?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.